Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
about
Interplay between Cellular and Molecular Inflammatory Mediators in Lung CancerRelationships between chronic obstructive pulmonary disease and lung cancer: biological insightsInferring condition-specific targets of human TF-TF complexes using ChIP-seq data.Inhibition of lung cancer growth by HangAmDan-B is mediated by macrophage activation to M1 subtypeDiversity and Versatility of Phagocytosis: Roles in Innate Immunity, Tissue Remodeling, and Homeostasis.Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.Negative Immune Regulator TIPE2 Promotes M2 Macrophage Differentiation through the Activation of PI3K-AKT Signaling PathwayMacrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast cancer cellsBreast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.IL-1α and IL-1β-producing macrophages populate lung tumor lesions in miceCancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway.Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1αinduced IL-10Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse modelIL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound PaclitaxelmiR-708-5p: a microRNA with emerging roles in cancer.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells.Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment.NF-kappaB: Two Sides of the Same Coin.Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Microscale Gene Expression Analysis of Tumor-Associated Macrophages.Characterization of cluster of differentiation 47 expression and its potential as a therapeutic target in esophageal squamous cell cancer.Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.Regulation of Immune Cell Functions by Metabolic Reprogramming.Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages.Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples.Role of Human Macrophage Polarization in Inflammation during Infectious Diseases.Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaIdentifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAttenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic MetastasisExploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission
P2860
Q26768652-2B6EB0E3-BA8F-4286-B7FF-F643CBA254FEQ28077681-F5E2494E-EB20-41A5-B404-7CD0B42A378BQ31153687-F567EBA3-DD28-4B6E-8C06-70C2C4F6C9A4Q33598678-4DFD6877-3DFF-4626-BFCE-CEF4ADE27D21Q33715167-0B6F9A6B-A150-497C-AE37-04387C496B3AQ33786852-DD1FEC69-6435-4995-A805-BC3C1016B214Q36259892-6F40C8F7-0336-4FFF-81B2-85CD281E191AQ37222123-9009BB0F-64FC-4AA5-88BA-A4CD03E8EDCAQ37456793-82E3B0B1-91A8-4855-83A7-68CBEA5E95A8Q37629006-A0F396B8-9034-490B-BFA6-B6C9A880A82FQ37630828-36C50B2B-E326-41A1-B372-6AD6A3422E8FQ39181831-84ACE54D-3195-4AC9-90EF-25703D2CC97EQ40082476-DBEAEFAA-B5FE-4621-B83E-3968A9B9B419Q41471218-C2ABA5E6-3BA7-4625-8B6B-2D10BCFB0A03Q41550052-4D228B4A-E82E-44D6-A98B-F52BD6C43F07Q41972983-3913BECC-6AD5-4F88-9069-B474E2163F17Q42200199-4D5CE696-8032-489E-823D-76007034D986Q42378530-AD5B8C11-4F28-4C73-BC30-E2A68270AE63Q47093975-2544411C-6A25-49A6-9FD9-493521A8D060Q47148987-7278860D-9CCF-43A8-8A4E-7D952557F10DQ47554669-10C58B0E-A454-43C4-B70F-0695C8781656Q47556651-85AE8A23-CC9F-48BC-9330-60BA63952018Q48290538-0DFE477A-8145-4533-865C-1981E8D50998Q48308048-577CFCC9-38F6-4626-ABC7-B3645F30B860Q49332562-BCE78ED6-1AC6-472A-8E20-E29ECE50A6FAQ49334850-CD4A66BE-C6F9-42C8-8E75-5E890C003CCEQ49609112-E5405EBD-ABD0-48DB-A619-71E94D61A78CQ50535273-A8A91086-80DA-4ECC-80B8-A2CF186F2C63Q52338220-FFDB040B-073B-4403-88C0-4AACACB07F55Q54952659-F6E2E97C-7C33-4467-82E1-A1E4447E7D81Q55220333-348C66F2-99A7-412A-8CFB-DF5C33F74F65Q55266134-D1368D30-1C98-4C52-83B6-2F15E89A6A2BQ55323964-3385324B-73D2-48E2-BB5F-52DB458CAEC6Q55378779-DF544071-0B21-4C3F-A242-FEAE3FA69C5BQ55453667-37EE0925-1949-4EB0-A6E9-16798BF44D92Q55716397-52BF201E-1212-4354-B33A-B023C34F17CBQ56929146-BE5A3078-68CB-48A4-8AD7-2C19F83F7F0AQ57216049-C451A034-26A3-4901-AE7E-06AD6AF7129CQ58590850-1E0616B6-9278-472C-BB3C-F275CA32CCE2Q58763679-8FD4D1C9-3308-4DE3-AB46-D5F3F344FA36
P2860
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@ast
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@en
type
label
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@ast
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@en
prefLabel
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@ast
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.
@en
P2093
P2860
P50
P356
P1433
P1476
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
@en
P2093
Hsuan-Yu Chen
Huei-Wen Chen
Jeremy J W Chen
Pan-Chyr Yang
Tsai-Hsia Hong
Yi-Chia Liu
Yi-Jing Hsiao
Yu-Yun Chen
P2860
P2888
P356
10.1038/SREP14273
P407
P577
2015-09-24T00:00:00Z